Primary care uniquely positions us to be our patients ’ best allies
My patient
The day I met you was early in my second year of internal medicine residency. After much of my internship had been spent on arduous inpatient rotations, I was finally ready to lead my own team of young doctors and students on a high-acuity wards service. Yet, in my continuity clinic, I was still fresh, insecure, and naive. The day I met you, your abdomen was swollen, your eyes were yellow, you were drowsy and seemingly apathetic. Years of heavy alcohol use had sclerosed your liver, leading to hepatic disease in its final stages. You were my patient, I was your new primary care doctor — and I didn’t speak you...
Source: Kevin, M.D. - Medical Weblog - September 18, 2018 Category: General Medicine Authors: < a href="https://www.kevinmd.com/blog/post-author/ashley-mcmullen" rel="tag" > Ashley McMullen, MD < /a > Tags: Physician Hospital-Based Medicine Source Type: blogs
The cirrhosis chalk talk
Some days on ward rounds we have time for relatively short chalk talks. Over the years I have developed many. Learners seem to like this one in particular.
We start with this question – name complications that cirrhotic patients develop for which we have secondary prevention. Knowing this list and the associated drugs allows us to peruse the drug list to add to the PMH when it is not readily available.
Here is my list:
Esophageal varices – most patients with significant varices are taking a non-specific beta blocker. More recently evidence suggests that carvedilol might be better than propranolol or nad...
Source: DB's Medical Rants - April 2, 2018 Category: Internal Medicine Authors: rcentor Tags: Medical Rants Source Type: blogs
No signs of abuse potential for eluxadoline within IBS with diarrhea
(HealthDay)—For patients with irritable bowel syndrome with diarrhea (IBS-D), there are simply no signs of abuse potential for eluxadoline, based on a study published in the July problem of Clinical Gastroenterology and Hepatology.
Related Posts:Eluxadoline eases pain and diarrhea for a few with IBSNew IBS treatment shows possible in Phase 2 researchCustomized rye bread helps patients along with irritable…Rifaximin effective for repeat treatment of IRRITABLE BOWEL…Higher functional GI disorders often overlap with IBSThe post No signs of abuse potential for eluxadoline within IBS with diarrhea appeared first...
Source: My Irritable Bowel Syndrome Story - July 10, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Defense profile differs during symptom flare, free in IBS-D
(HealthDay)—For patients with irritable bowel symptoms with diarrhea (IBS-D), interferon-γ concentrations and THELPER cells are inhibited during symptom flare, according to a research letter published online June ten in Gut.
Related Posts:Eluxadoline eases pain and diarrhea for a few with IBSResearchers report breakthrough inhibition of intestinal…Rifaximin effective for repeat treatment of IRRITABLE BOWEL…What Are The Chances Of Ovarian Cancer And Ibs Diagnosis…New IBS treatment shows possible in Phase 2 researchThe post Defense profile differs during symptom flare, free in IBS-D appeared first on ...
Source: My Irritable Bowel Syndrome Story - June 26, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Rifaximin effective for repeat treatment of IRRITABLE BOWEL SYNDROME with diarrhea
(HealthDay)—Repeat treatment with the nonsystemic antibiotic rifaximin works well in patients with relapsing symptoms of diarrhea-predominant irritable bowel syndrome (IBS-D), according to a study published in the December issue of Gastroenterology.
Related Posts:Evaluation suggests yoga beneficial in irritable bowel…Eluxadoline eases pain and diarrhea for a few with IBSTreatment for IBS With Severe ConstipationRifimax to Treat IBSLow FODMAP diet cuts irritable bowel syndrome symptomsThe post Rifaximin effective for repeat treatment of IRRITABLE BOWEL SYNDROME with diarrhea appeared first on My Irritable Bowel Syn...
Source: My Irritable Bowel Syndrome Story - December 27, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
A Year in Review: FDA 2015 New Drug Approvals
The approval of first-of-a-kind drugs rose last year to forty-one, resulting in the highest level of newly approved U.S. drugs in nineteen years. The total number of new drugs approved last year was even higher at sixty-nine. The rising figures reflect an industry-wide desire to research and develop drugs for rare and hard-to-treat diseases.
The newly approved drugs serve to advance medical care and the health of patients suffering from many ailments, including various forms of cancer, heart failure, and cystic fibrosis. Additionally, more than 40% of the new therapies were approved for treatment of rare or "orphan" dise...
Source: Policy and Medicine - January 13, 2016 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs
Management of hepatic encephalopathy in hospital
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); Review ArticleLeise MD, Poterucha J, Kamath PS et. al. Management of hepatic encephalopathy in the hospital. Mayo Clin Proc 2014; 89(2) 241-253.Working Party for hepatic encephalopathy nomenclature:Type A HE-- secondary to liver failureType B HE enteric hyperammonemia without liver diseasevar pageTracker = _gat._getTracker("UA-3639768-12"); pageTracker._initData(); pageTracker._trackPageview(); T...
Source: neurologyminutiae - May 16, 2014 Category: Neurologists Source Type: blogs
